Notch Signaling in Cartilage Development

软骨发育中的Notch信号传导

基本信息

  • 批准号:
    7983901
  • 负责人:
  • 金额:
    $ 34.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-02 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Signaling pathway components such as Ihh/Pthrp, TGF¿, BMPs, Wnt/¿-catenin, FGFs, and Sox-related proteins represent important regulators of cartilage formation and development. These same signaling pathways and related molecules are being targeted for clinical treatment of cartilage injuries and diseases (osteoarthritis, rheumatoid arthritis, and fracture repair) and cartilage tissue engineering applications (maintenance and manipulation of mesenchymal progenitor cells (MPCs)). We provide original, unpublished data indicating that the Notch signaling pathway is another important regulator of MPC differentiation and chondrocyte maturation, leading to questions regarding the mechanisms by which Notch controls these processes. To begin addressing these questions, we propose to test the novel hypothesis that RBPj?-dependent Notch signaling suppresses MPC differentiation and chondrogenesis by interacting with stabilized ¿-catenin to regulate Hes1 and ultimately Sox9, and is later required to promote chondrocyte maturation via cartilage specific regulation of Hes1 and Runx2 activities. To test these hypotheses, we will address two Specific Aims. Experiments in Specific Aim 1 will investigate whether Hes1 is required for MPC differentiation and chondrogenesis or the Notch-mediated suppression of MPC differentiation using limb mesenchyme specific conditional loss-of-function and genetic rescue mouse models. Secondly, we will determine whether the Wnt/beta-catenin signaling pathway is necessary and sufficient for Notch mediated induction of Hes1 and suppression of MPC differentiation. Finally, we will determine whether Hes1 suppresses MPC differentiation by directly regulating Sox9 expression. Specific Aim 2 will first examine the potential roles for both RBPJ?- dependent and -independent Notch signaling in promoting chondrocyte maturation using various tissue specific Notch gain- and loss-of-function mouse models. Additionally, we will perform in vitro experiments using primary chondrocyte cultures to identify RBPJ?-dependent Notch targets that regulate chondrocyte maturation and examine whether Notch mediates Wnt/beta-catenin or BMP signaling during this process. Secondly, we will use two different conditional Hes1 mutant mouse models to determine whether Hes1 is the primary RBPJk-dependent Notch regulator of chondrocyte maturation. Finally, in vitro studies will be performed to determine whether Hes1 promotes Runx2 activity and chondrocyte maturation via competitive interactions with the mutual co-repressor, Groucho related gene (Grg1). Completion of these aims will identify the Notch signaling mechanisms important in regulating MPC maintenance and expansion, as well as, chondrocyte maturation. These molecules will likely serve as therapeutic targets for cartilage injuries or diseases and provide us with potential tools for use in cartilage tissue engineering applications. PUBLIC HEALTH RELEVANCE: We have identified the RBPJ?-dependent Notch pathway as an important regulator of MPC differentiation and chondrocyte maturation. Our proposal will determine the exact Notch signaling mechanisms responsible for suppressing chondrogenic commitment from mesenchymal progenitor cells (MPCs) and for promoting chondrocyte maturation. Data generated by this proposal will likely implicate specific Notch signaling molecules as potential therapeutic targets for cartilage related injuries and diseases, as well as, provide potential tools in MPC maintenance and expansion for use in tissue engineering applications.
描述(由申请人提供):信号通路组分如Ihh/Pthrp、TGF β、BMP、Wnt/β-连环蛋白、FGF和Sox相关蛋白代表软骨形成和发育的重要调节剂。这些相同的信号通路和相关分子被靶向用于软骨损伤和疾病(骨关节炎、类风湿性关节炎和骨折修复)的临床治疗和软骨组织工程应用(间充质祖细胞(MPC)的维持和操作)。我们提供了原始的,未发表的数据表明,Notch信号通路是MPC分化和软骨细胞成熟的另一个重要调节因子,导致有关Notch控制这些过程的机制的问题。为了开始解决这些问题,我们建议测试新的假设,RBPj?依赖性Notch信号通过与稳定的β-连环蛋白相互作用以调节Hes 1并最终调节Sox 9来抑制MPC分化和软骨形成,并且随后需要通过软骨特异性调节Hes 1和Runx 2活性来促进软骨细胞成熟。为了验证这些假设,我们将讨论两个具体目标。特定目标1中的实验将使用肢体间充质特异性条件性功能丧失和遗传拯救小鼠模型研究Hes 1是否是MPC分化和软骨形成所需的,或者是Notch介导的MPC分化抑制。其次,我们将确定Wnt/β-catenin信号通路是否是Notch介导的Hes 1诱导和MPC分化抑制所必需和充分的。最后,我们将确定Hes 1是否通过直接调节Sox 9表达来抑制MPC分化。具体目标2将首先检查RBPJ?使用各种组织特异性Notch功能获得和丧失小鼠模型,研究了依赖性和非依赖性Notch信号传导在促进软骨细胞成熟中的作用。此外,我们将使用原代软骨细胞培养物进行体外实验,以鉴定RBPJ?依赖性Notch靶点调节软骨细胞成熟,并检查Notch是否在此过程中介导Wnt/β-连环蛋白或BMP信号传导。其次,我们将使用两种不同的条件性Hes 1突变小鼠模型来确定Hes 1是否是软骨细胞成熟的主要RBPJK依赖性Notch调节因子。最后,将进行体外研究,以确定Hes 1是否通过与相互辅阻遏物Groucho相关基因(Grg 1)的竞争性相互作用促进Runx 2活性和软骨细胞成熟。这些目标的完成将确定Notch信号传导机制在调节MPC维持和扩增以及软骨细胞成熟中的重要性。这些分子将可能作为软骨损伤或疾病的治疗靶点,并为我们提供用于软骨组织工程应用的潜在工具。 公共卫生相关性:我们已经确定了RBPJ?依赖性Notch途径作为MPC分化和软骨细胞成熟的重要调节剂。我们的建议将确定确切的Notch信号转导机制负责抑制软骨形成的承诺从间充质祖细胞(MPC)和促进软骨细胞成熟。由该提议产生的数据将可能暗示特定的Notch信号传导分子作为软骨相关损伤和疾病的潜在治疗靶标,以及提供MPC维持和扩展的潜在工具以用于组织工程应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew J. Hilton其他文献

Matthew J. Hilton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew J. Hilton', 18)}}的其他基金

Notch Signaling in Endochondral Bone Development
软骨内骨发育中的Notch信号传导
  • 批准号:
    9761983
  • 财政年份:
    2018
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Endochondral Bone Development
软骨内骨发育中的Notch信号传导
  • 批准号:
    10480088
  • 财政年份:
    2018
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Joint Cartilage Maintenance and Arthritis
关节软骨维护和关节炎中的 Notch 信号传导
  • 批准号:
    8502631
  • 财政年份:
    2012
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Joint Cartilage Maintenance and Arthritis
关节软骨维护和关节炎中的 Notch 信号传导
  • 批准号:
    8879046
  • 财政年份:
    2012
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Joint Cartilage Maintenance and Arthritis
关节软骨维护和关节炎中的 Notch 信号传导
  • 批准号:
    8664814
  • 财政年份:
    2012
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Joint Cartilage Maintenance and Arthritis
关节软骨维护和关节炎中的 Notch 信号传导
  • 批准号:
    8340885
  • 财政年份:
    2012
  • 资助金额:
    $ 34.48万
  • 项目类别:
Histology, Biochemistry and Molecular Imaging Core
组织学、生物化学和分子成像核心
  • 批准号:
    8186756
  • 财政年份:
    2011
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Cartilage Development
软骨发育中的Notch信号传导
  • 批准号:
    8104204
  • 财政年份:
    2010
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Cartilage Development
软骨发育中的Notch信号传导
  • 批准号:
    8256561
  • 财政年份:
    2010
  • 资助金额:
    $ 34.48万
  • 项目类别:
Notch Signaling in Cartilage Development
软骨发育中的Notch信号传导
  • 批准号:
    8654294
  • 财政年份:
    2010
  • 资助金额:
    $ 34.48万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 34.48万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 34.48万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 34.48万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 34.48万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了